The problem of transplantation – at least in the case of the kidney

The problem of transplantation – at least in the case of the kidney

The problem of transplantation – at least in the case of the kidney

“The problem of transplantation – at least in the case of the kidney – is that there is still no definitively established one o…

NanoGroup S.A. launches another research stage with the use of its original innovative organ perfusion fluid

NanoGroup S.A. launches another research stage with the use of its original innovative organ perfusion fluid

After announcing positive results from preliminary studies comparing kidneys perfused with NanOX 10 and NanOX 20 fluids with the current standard used in t…

NanoGroup S.A. is launching the next phase of research with a proprietary innovative organ perfusion fluid

NanoGroup S.A. is launching the next phase of research with a proprietary innovative organ perfusion fluid

After announcing positive results from preliminary studies comparing kidneys perfused with NanOX 10 and NanOX 20 fluids with the current standard used in t…

NanoGroup S.A. continues advanced works on an innovative organ perfusion fluid and device

NanoGroup S.A. continues advanced works on an innovative organ perfusion fluid and device

For 18 years now, January 26 has been the National Transplantation Day. Transplantation is one of the areas close to NanoGroup S.A.’s business. The c…

NanoVelos SA in pharmaceutical industry report

NanoVelos SA in pharmaceutical industry report

We are in “Report on pharmaceutical and cosmetics industry in Warsaw “. The publication includes. Information on projects i…

Przemyslaw Mazurek joins the team and becomes CEO.

Przemyslaw Mazurek joins the team and becomes CEO.

We are pleased to announce that Przemyslaw Mazurek has joined NanoGroup to take on the role of CEO. He knows the Company quite well fro…

pp-thumbnail